GSK2807 Trifluoroacetate
GSK2807 Trifluoroacetate is a potent and selective SMYD3 inhibitor that competes with S-adenosylmethionine (SAM), exhibiting a Ki of 14 nM and an IC50 of 130 nM. This compound is a valuable chemical probe for studying SMYD3's role in oncology and epigenetics, supporting both in vitro biochemical assays and in vivo cancer model research.
Product Specifications
CAS Number
2245255-66-5
Product Name Alternative
Inhibit, Inhibitor, GSK 2807, GSK 2807 Trifluoroacetate, GSK-2807, GSK2807 Trifluoroacetate, GSK-2807 Trifluoroacetate, GSK2807, Histone Methyltransferase, HistoneMethyltransferase, SMYD3
Field of Research
Epigenetics & Chromatin
Purity
99.61% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.53 mM) ; H2O:50 mg/mL (88.26 mM)
Smiles
OC (=O) C (F) (F) F.CN (C) CCCN (CC[C@H] (N) C (O) =O) C[C@H]1O[C@H] ([C@H] (O) [C@@H]1O) n1cnc2c (N) ncnc12
Molecular Formula
C21H33F3N8O7
Molecular Weight
566.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GM-105-15 1 mL
Colloidal Gold Conjugated Monoclonal Antibody to Human IgA1, 15nm
Sign In for Pricing
View Details 
BNC942226-500 1x 500 µL
FABP2 (Marker of Metastatic Potential in Colorectal Cancer) (CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details